EVALUATING THE RELATIONSHIP BETWEEN HUMAN PAPILLOMA VIRUS INFECTIONS, PROSTATE CANCER AND INTERLEUKIN-12 LEVELS
Sadegh Moradi,
Mohammad Rashno,
Mohsen Sarkarian,
Gholam Abbas Kaydani,
Ladan Fatahi,
Maryam Seyedtabib,
Moosa Shariffat, 
Ali Khodadadi
Ali Khodadadi https://doi.org/10.15789/10.15789/1563-0625-CCO-2690
Аннотация
Abstract
Prostate cancer (PC); is the second leading cause of cancer mortality among men. Human papillomavirus (HPV) is the most common cause of cervical cancer, strongly associated with anal and vaginal cancers. Also, interleukin-12 (IL-12) induces antitumor immunity. This study aimed to investigate the role of HPV in PC; and determine its effects on serum IL-12.
Between 2018 and 2022 in Ahvaz, researchers obtained 55 paraffin samples of malignant prostate lesions and 55 control samples of benign hyperplasia tissues from the prostate. Blood samples were collected from 24 diagnosed cancer patients to assess IL-12 levels before treatment initiation. Additionally, 24 patients with benign prostatic hyperplasia participated as controls. We performed DNA extraction using the phenol-chloroform method and examined the presence of papillomavirus DNA in tissues through Nested-PCR. Subsequently, IL-12 levels in serum were measured using ELISA.
The findings did not show the relationship between HPV and PC; HPV infection was not correlated to the presence of IL-12 secretion. However, with the progression of cancer, the level of IL-12 decreased significantly in patients compared to the control group (P<0.05).
HPV infection can exist in prostate tissue, although this does not mean that it contributes to P.C. development. The most significant strains infecting prostate tissue are types 16 and 18. Compared to the control group and with different Gleason scores, prostate cancer patient's levels of interleukin-12 secretion are significantly lower. One can make effective measures to assess the prognosis, regulate the condition, or aid in treating individuals using this crucial cytokine.
Об авторах
Sadegh Moradi
Ahvaz Jundishapur University of Medical Sciences , Ahvaz, Iran
Иран
Иран
Mohammad Rashno
Ahvaz Jundishapur University of Medical Sciences , Ahvaz, Iran
Иран
Иран
Mohsen Sarkarian
Ahvaz Jundishapur University of Medical Sciences , Ahvaz, Iran
Иран
Иран
Gholam Abbas Kaydani
Ahvaz Jundishapur University of Medical Sciences , Ahvaz, Iran
Иран
Иран
Ladan Fatahi
Ahvaz Jundishapur University of Medical Sciences , Ahvaz, Iran
Иран
Иран
Maryam Seyedtabib
Ahvaz Jundishapur University of Medical Sciences , Ahvaz, Iran
Иран
Иран
Moosa Shariffat
Ahvaz Jundishapur University of Medical Sciences , Ahvaz, Iran
Иран
Иран
Ali Khodadadi
Ahvaz Jundishapur University of Medical Sciences , Ahvaz, Iran
Россия
Россия
Список литературы
1. Rosalik k , Tarney c , Han j
2. Human Papilloma Virus Vaccination Viruses https://pubmed.ncbi.nlm.nih.gov/34201028/
3. DOI: 10.3390/v13061091
4. Yu L , Majerciak V , Zheng Z-M
5. HPV16 and HPV18 Genome Structure, Expression, and Post-Transcriptional Regulation Int J Mol Sci https://pubmed.ncbi.nlm.nih.gov/35563334/
6. DOI: 10.3390/ijms23094943
7. Minichsdorfer, C
8. HPV-associated cancers. memo - Magazine of European Medical Oncology https://link.springer.com/article/10.1007/s12254-019-00551-6
9. Okunade, K.S.
10. Human papillomavirus and cervical cancer J Obstet Gynaecol https://pubmed.ncbi.nlm.nih.gov/31500479/
11. DOI: 10.1080/01443615.2019.1634030
12. Russo G , Calogero A.E , Condorelli R.A , Scalia G , Morgia G , Vignera S.L
13. Human papillomavirus and risk of prostate cancer: a systematic review and meta-analysis Aging Male https://pubmed.ncbi.nlm.nih.gov/29571270/
14. DOI: 10.1080/13685538.2018.1455178
15. Videla S , Darwich L , Cañadas M , Clotet B , Sirera G
16. Incidence and clinical management of oral human papillomavirus infection in men: a series of key short messages Expert Rev Anti Infect Ther https://pubmed.ncbi.nlm.nih.gov/24865412/
17. DOI: 10.1586/14787210.2014.922872
18. Bagcchi, S
19. Harald zur Hausen The Lancet Infectious Diseases https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00511-X/fulltext
20. DOI:https://doi.org/10.1016/S1473-3099(23)00511-X
21. Amadi, V., N. Nwiabu, and V. Anireh,
22. Case-Based Reasoning System for the Diagnosis and Treatment of Breast, Cervical and Prostate Cancer SSRG International Journal of Computer Science and Engineering https://www.internationaljournalssrg.org/IJCSE/paper-details?Id=454
23. DOI: 10.14445/23488387/IJCSE-V8I8P103
24. Lawson J.S , Glenn W.K
25. Evidence for a causal role by human papillomaviruses in prostate cancer - a systematic review Infect Agent Cancer https://pubmed.ncbi.nlm.nih.gov/32684946/
26. DOI: 10.1186/s13027-020-00305-8
27. Khatami A , Sadri Nahand J , Kiani S.J , Khoshmirsafa M , Moghoofei M , Khanaliha K , Tavakoli A , Emtiazi N , Bokharaei-Salim F
28. Human papilloma virus (HPV) and prostate cancer (PCa): The potential role of HPV gene expression and selected cellular MiRNAs in PCa development Microb Pathog https://pubmed.ncbi.nlm.nih.gov/35398468/
29. DOI: 10.1016/j.micpath.2022.105503
30. Croxford A.L , Kulig P , Beche B
31. IL-12-and IL-23 in health and disease Cytokine Growth Factor Rev https://pubmed.ncbi.nlm.nih.gov/25130295/
32. DOI: 10.1016/j.cytogfr.2014.07.017
33. Negin, F.A.,
34. Immunotherapy of Prostate Cancer by a Combination of Treatments Aiming at Activation of OX40 and Intratumoral Production of IL-12. Amazon https://books.google.com/books/about/Immunotherapy_of_Prostate_Cancer_by_
35. a_Co.html?id=X6yVzwEACAAJ
36. Habiba U.e , Rafiq M ,
37. Khawar M.B , Nazir B ,
38. Haider G, Nazir N
39. The multifaceted role of IL-12 in cancer. Advances in Cancer Biology - Metastasis https://www.sciencedirect.com/science/article/pii/S2667394022000272?via%3Dihub
40. DOI: 10.1016/j.adcanc.2022.100053
41. Yin X , Yan X , Yang Q , Cao H , Liang H .
42. Antitumor mechanism of recombinant murine interleukin-12 vaccine Cancer Biother Radiopharm https://pubmed.ncbi.nlm.nih.gov/20578831/
43. DOI: 10.1089/cbr.2010.0771
44. Paz F.G , Marina V.M , Ortega A.M , González A.S , Zaragoza O.P , García A.B , Poveda K.T , Moreno J , González J.A , Marquez E.H , Morales V.B
45. The relationship between the antitumor effect of the IL-12 gene therapy and the expression of Th1 cytokines in an HPV16-positive murine tumor model Mediators Inflamm https://pubmed.ncbi.nlm.nih.gov/24808638/
46. DOI: 10.1155/2014/510846
47. Berraondo P , Prieto J , Aseguinolaza G.G
48. Advances in interleukin-12 gene therapy for acquired liver diseases Curr Gene Ther https://pubmed.ncbi.nlm.nih.gov/19355864/
49. DOI: 10.2174/156652309787909553
50. Mahvi D.M , Henry M.B , Albertini M R , Weber S , Meredith K , Schalch H , Rakhmilevich A , Hank J , Sondel P
51. Intratumoral injection of IL-12 plasmid DNA--results of a phase I/IB clinical trial Cancer Gene Ther https://pubmed.ncbi.nlm.nih.gov/17557109/
52. DOI: 10.1038/sj.cgt.7701064
53. Tugues S , Burkhard S.H , Ohs I , Vrohlings M , Nussbaum K , Vom Berg J , Kulig P , Becher B
54. New insights into IL-12-mediated tumor suppression Cell Death Differ
55. https://pubmed.ncbi.nlm.nih.gov/25190142/
56. DOI: 10.1038/cdd.2014.134
57. Shi G , Edelblute C, Arpag S , Lundberg C , Heller R
58. IL-12 Gene Electrotransfer Triggers a Change in Immune Response within Mouse Tumors Cancers (Basel) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315808/
59. doi: 10.3390/cancers10120498
60. Torres-Poveda K , Bahena-Román M , Madrid-González C , Burguete-García A , Bermúdez-Morales V.H , Peralta-Zaragoza O , Madrid-Marina V
61. Role of IL-10 and TGF-β1 in local immunosuppression in HPV-associated cervical neoplasia World J Clin Oncol https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4129538/
62. doi: 10.5306/wjco.v5.i4.753
63. Ma W , Wang K , Du J , Luan J , Lou G
64. Multi-dose parecoxib provides an immunoprotective effect by balancing T helper 1 (Th1), Th2, Th17 and regulatory T cytokines following laparoscopy in patients with cervical cancer Mol Med Rep https://pubmed.ncbi.nlm.nih.gov/25434365/
65. doi: 10.3892/mmr.2014.3003. Epub 2014 Nov 26.
66. Bermúdez-Morales V.H , Peralta-Zaragoza O , Alcocer-González J.M , Moreno J , Madrid-Marina V
67. IL-10 expression is regulated by HPV E2 protein in cervical cancer cells Mol Med Rep https://pubmed.ncbi.nlm.nih.gov/21468579/
68. DOI: 10.3892/mmr.2011.429
69. Feng Q , Wei H , Morihara J , Stern J , Yu M , Kiviat N, Hellstrom I , Hellstrom K.E
70. Th2 type inflammation promotes the gradual progression of HPV-infected cervical cells to cervical carcinoma Gynecol Oncol https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472044/
71. doi: 10.1016/j.ygyno.2012.07.098
72. Bermúdez-Morales V.H , Fierros-Zarate G , García-Meléndrez C , Alcocer-Gonzalez J.M , Morales-Ortega A , Peralta-Zaragoza O , Torres-Poveda k , Burguete-García AI , Hernández-Márquez E , Madrid-Marina V
73. In vivo Antitumor Effect of an HPV-specific Promoter driving IL-12 Expression in an HPV 16-positive Murine Model of Cervical Cancer J Cancer https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118658/
74. doi: 10.7150/jca.15536
75. Marcuccilli F , Farchi F , Mirandola W , Ciccozzi M , Paba P , Bonanno E , Perno C.F , Ciotti M
76. Performance evaluation of Anyplex™II HPV28 detection kit in a routine diagnostic setting: comparison with the HPV Sign® Genotyping Test J Virol Methods https://pubmed.ncbi.nlm.nih.gov/25724435/
77. DOI: 10.1016/j.jviromet.2015.02.018
78. Mesri E.A , Feitelson M.A , Munger K
79. Human viral oncogenesis: a cancer hallmarks analysis Cell Host Microbe
80. https://pubmed.ncbi.nlm.nih.gov/24629334/
81. DOI: 10.1016/j.chom.2014.02.011
82. Guma S , Maglantay R , Lau R , Wieczorek R , Melamed J , Deng F.M , Zhou M , Makarov D , Lee P , Pincus M.R , Pei Z.H
83. Papillary urothelial carcinoma with squamous differentiation in association with human papilloma virus: case report and literature review Am J Clin Exp Urol https://pubmed.ncbi.nlm.nih.gov/27069958/
84. Tolstov Y , Hadaschik B , Pahernik S , Hohenfellner M , Duensing S
85. Human papillomaviruses in urological malignancies: a critical assessment Urol Oncol https://pubmed.ncbi.nlm.nih.gov/24140249/
86. DOI: 10.1016/j.urolonc.2013.06.012
87. Yang L , Xie S , Feng X , Chen Y , Zheng T , Dai M , Zhou C.k , Hu Z , Li N , Hanga D
88. Worldwide Prevalence of Human Papillomavirus and Relative Risk of Prostate Cancer: A Meta-analysis Sci Rep https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4594101/
89. doi: 10.1038/srep14667
90. Nahand J.S , Esghaei M , Monavari S.H , Moghoofei M , Kiani S.J , Mostafaei S , Mirzaei H , Bokharaei-Salim F
91. The assessment of a possible link between HPV-mediated inflammation, apoptosis, and angiogenesis in Prostate cancer Int Immunopharmacol
92. https://pubmed.ncbi.nlm.nih.gov/32889239/
93. DOI: 10.1016/j.intimp.2020.106913
94. Shariat A , Arzani P , Shirali M
95. Studying the Association Between Human Papillomavirus and Prostate Cancer by Immunohistochemistry and PCR Techniques in Ahvaz Hospitals Jundishapur Scientific Medical Journal (JSMJ) https://jsmj.ajums.ac.ir/article_115486.html?lang=en
96. 22118/jsmj.2020.229601.2074
97. Michopoulou V , Derdas S.P , Symvoulakis E , Mourmouras N , Nomikos A , Delakas D , Sourvinos G , Spandidos D.A
98. Detection of human papillomavirus (HPV) DNA prevalence and p53 codon 72 (Arg72Pro) polymorphism in prostate cancer in a Greek group of patients Tumour Biol
99. https://pubmed.ncbi.nlm.nih.gov/25213701/
100. DOI: 10.1007/s13277-014-2604-7
101. Medel-Flores O , Valenzuela-Rodríguez V.A , Ocadiz-Delgado R , Castro-Muñoz L.J , Hernández-Leyva S , Lara-Hernández G , Silva-Escobedo J.G , Vidal P.G , Sánchez-Monroy V
102. Association between HPV infection and prostate cancer in a Mexican population Genet Mol Biol https://pubmed.ncbi.nlm.nih.gov/30508006/
103. DOI: 10.1590/1678-4685-GMB-2017-0331
104. Moghoofei M , Keshavarz M , Ghorbani S , Babaei F , Nahand J.S , Tavakoli A , Mortazavi H.S , Marjani A , Mostafaei S , Monavari S.H
105. Association between human papillomavirus infection and prostate cancer: A global systematic review and meta-analysis Asia Pac J Clin Oncol
106. https://pubmed.ncbi.nlm.nih.gov/30740893/
107. DOI: 10.1111/ajco.13124
108. Atashafrooz F , Rokhbakhsh-Zamin F
109. Frequency and Type Distribution of Human Papilloma Virus in Patients with Prostate Cancer, Kerman, Southeast of Iran Asian Pac J Cancer Prev https://pubmed.ncbi.nlm.nih.gov/27644644/
110. Chen A C-H, Waterboer T , Keleher A , Morrison B , Jindal S , McMillan D , Nicol D , Gardiner R.A , McMillan N.A.J , Antonsson A
111. Human papillomavirus in benign prostatic hyperplasia and prostatic adenocarcinoma patients Pathol Oncol Res https://pubmed.ncbi.nlm.nih.gov/21240663/
112. DOI: 10.1007/s12253-010-9357-4
113. Samiraa M , Abolfazlb J.S , Rozita N , Hossein Bannazadehd B
114. Prostate cancer and human papillomavirus infection: a recent literature review Reviews and Research in Medical Microbiology https://journals.lww.com/revmedmicrobiol/abstract/2022/04000/prostate_cancer_and_human_papillomavirus.5.aspx
115. DOI: 10.1097/MRM.0000000000000261
116. Usman M, Ahmad M , Hameed Y , Ahmed H , Safdar Hussain M ,Rehman J.U , Arshad R , Atif M
117. Identification of correlation betweenhuman papillomavirus and prostate cancer:Bradford Hill Criteria Based Evaluation nternational Journal of Endorsin https://www.researchgate.net/publication/352257684_Identification_of_correlation_between_human_papillomavirus_and_prostate_cancer_Bradford_Hill_Criteria_Based_Evaluation
118. Doi: 10.29052/IJEHSR.v9.i2.2021.248-256
119. Bello R.O , Willis-Powell L , James O , Sharma A , Marsh E , Ellis L , Gaston K , Siddiqui Y
120. Does Human Papillomavirus Play a Causative Role in Prostate Cancer? A Systematic Review Using Bradford Hill's Criteria Cancers (Basel) https://pubmed.ncbi.nlm.nih.gov/37568712/
121. DOI: 10.3390/cancers15153897
122. Bae J.M
123. Human papillomavirus 16 infection as a potential risk factor for prostate cancer: an adaptive meta-analysis Epidemiol Health https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371392/
124. doi: 10.4178/epih/e2015005
125. Guenova E , Volz T , Sauer K , Kaesler S , Müller M.R , Wölbing F , Chen K , Schwärzler C , Brossart P , Röcken M , Biedermann T
126. IL-4-mediated fine tuning of IL-12p70 production by human DC Eur J Immunol https://pubmed.ncbi.nlm.nih.gov/18924208/
127. DOI: 10.1002/eji.200838463
128. Salimu J , Webber J , Gurney M , Al-Taei S , Clayton A , Tabi Z
129. Dominant immunosuppression of dendritic cell function by prostate-cancer-derived exosomes J Extracell Vesicles https://pubmed.ncbi.nlm.nih.gov/28959385/
130. DOI: 10.1080/20013078.2017.1368823
131. Kundu M , Roy A , Pahan K
132. Selective neutralization of IL-12 p40 monomer induces death in prostate cancer cells via IL-12-IFN-γ Proc Natl Acad Sci U S A
133. https://pubmed.ncbi.nlm.nih.gov/29073075/
134. DOI: 10.1073/pnas.1705536114
135. Shekar Abi M , Bahar B , Behbin M , Atri M , Falak R , Imani M , Danesh p
136. The Evaluation of Serum Levels of IFN-, IL-12 and Percentage of CD4+, CD8+ and NK Cells in Peripheral Blood of Metastatic, Nonmetastatic Breast Cancer Patients and Normal Individuals Razi Journal of Medical Sciences (RJMS) https://rjms.iums.ac.ir/article-1-830-en.html
137. Kovacs E
138. The serum levels of IL-12 and IL-16 in cancer patients. Relation to the tumour stage and previous therapy Biomed Pharmacother https://pubmed.ncbi.nlm.nih.gov/11293814/
139. DOI: 10.1016/s0753-3322(00)00023-8
140. Murakami S , Okubo K , Tsuji Y , Sakata H , Hamada S , Hirayama R
141. Serum interleukin-12 levels in patients with gastric cancer Surg Today https://pubmed.ncbi.nlm.nih.gov/15580384/
142. DOI: 10.1007/s00595-004-2860-z
143. Jebreel A , Mistry D , Loke D , Dunn g , Hough V , Oliver K , Stafford N , Greenman J
144. Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer J Laryngol Otol
145. https://pubmed.ncbi.nlm.nih.gov/17040593/
146. DOI: 10.1017/S0022215106002428
Дополнительные файлы
|
1. title page | |
| Тема | ||
| Тип | Research Instrument | |
Скачать
(13KB)
|
Метаданные ▾ | |
|
|
2. abstract | |
| Тема | ||
| Тип | Research Instrument | |
Скачать
(13KB)
|
Метаданные ▾ | |
|
|
3. references | |
| Тема | ||
| Тип | Research Instrument | |
Скачать
(33KB)
|
Метаданные ▾ | |
|
|
4. Figure 1 | |
| Тема | ||
| Тип | Research Instrument | |
Скачать
(62KB)
|
Метаданные ▾ | |
|
|
5. Table 1 | |
| Тема | ||
| Тип | Research Instrument | |
Скачать
(55KB)
|
Метаданные ▾ | |
|
|
6. Table 2 | |
| Тема | ||
| Тип | Research Instrument | |
Скачать
(58KB)
|
Метаданные ▾ | |
|
|
7. Table 3 | |
| Тема | ||
| Тип | Research Instrument | |
Скачать
(54KB)
|
Метаданные ▾ | |
|
8. 3025 | |
| Тема | ||
| Тип | Прочее | |
Скачать
(68KB)
|
Метаданные ▾ | |
Рецензия
Для цитирования:
, , , , , , , . Медицинская иммунология. https://doi.org/10.15789/10.15789/1563-0625-CCO-2690
For citation:
Moradi S., Rashno M., Sarkarian M., Kaydani G., Fatahi L., Seyedtabib M., Shariffat M., Khodadadi A. EVALUATING THE RELATIONSHIP BETWEEN HUMAN PAPILLOMA VIRUS INFECTIONS, PROSTATE CANCER AND INTERLEUKIN-12 LEVELS. Medical Immunology (Russia). https://doi.org/10.15789/10.15789/1563-0625-CCO-2690
Просмотров:
34
Послать статью по эл. почте 